Delivra Health Brands Inc.
DHB.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.97M | 2.32M | 2.62M | 2.28M | 1.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.97M | 2.32M | 2.62M | 2.28M | 1.51M |
| Cost of Revenue | 1.04M | 1.15M | 1.28M | 1.14M | 695.30K |
| Gross Profit | 924.40K | 1.17M | 1.34M | 1.14M | 811.50K |
| SG&A Expenses | 1.15M | 1.23M | 1.33M | 1.03M | 929.10K |
| Depreciation & Amortization | 232.90K | 239.00K | 237.50K | 241.80K | 239.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.43M | 2.62M | 2.85M | 2.41M | 1.86M |
| Operating Income | -462.20K | -297.70K | -230.90K | -132.80K | -357.20K |
| Income Before Tax | -580.10K | -350.50K | 1.15M | -209.20K | -477.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -580.10K | -350.50K | 1.15M | -209.20K | -477.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -580.10K | -350.50K | 1.15M | -209.20K | -477.00K |
| EBIT | -462.20K | -297.70K | -230.90K | -132.80K | -357.20K |
| EBITDA | -229.30K | -58.70K | 11.70K | 108.30K | -118.30K |
| EPS Basic | -0.02 | -0.01 | 0.04 | -0.01 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.02 | -0.01 | 0.04 | -0.01 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 31.26M | 30.06M | 31.25M | 31.26M | 26.51M |
| Average Diluted Shares Outstanding | 31.26M | 30.06M | 31.25M | 42.04M | 26.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |